147 related articles for article (PubMed ID: 33556116)
21. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.
Xu Y; Zhou L; Zong J; Ye Y; Chen G; Chen Y; Liao X; Guo Q; Qiu S; Lin S; Chen H; Pan J
Oncotarget; 2017 Jun; 8(26):42007-42019. PubMed ID: 28159927
[TBL] [Abstract][Full Text] [Related]
22. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; Garay MCG; Suarez-Alvarez B; Lopez-Larrea C
Oncotarget; 2017 May; 8(19):31959-31976. PubMed ID: 28404876
[TBL] [Abstract][Full Text] [Related]
23. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.
Cerboni C; Zingoni A; Cippitelli M; Piccoli M; Frati L; Santoni A
Blood; 2007 Jul; 110(2):606-15. PubMed ID: 17405908
[TBL] [Abstract][Full Text] [Related]
24. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
[TBL] [Abstract][Full Text] [Related]
25. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
Wittenbrink M; Spreu J; Steinle A
Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
[TBL] [Abstract][Full Text] [Related]
26. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.
Salih HR; Antropius H; Gieseke F; Lutz SZ; Kanz L; Rammensee HG; Steinle A
Blood; 2003 Aug; 102(4):1389-96. PubMed ID: 12714493
[TBL] [Abstract][Full Text] [Related]
27. Characterization of 5' promoter and exon 1-3 polymorphism of the RAET1E gene.
Cox ST; Pearson H; Laza-Briviesca R; Pesoa S; Vullo C; Madrigal JA; Saudemont A
Hum Immunol; 2016 Jan; 77(1):96-103. PubMed ID: 26519211
[TBL] [Abstract][Full Text] [Related]
28. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of RAET1E/ULBP4 exon 4 and 3' untranslated region genetic architecture reveals further diversity and allelic polymorphism.
Cox ST; Haver DS; Patterson W; Cambridge CA; Turner TR; Danby RD; Hernandez D
HLA; 2024 Apr; 103(4):e15457. PubMed ID: 38575368
[TBL] [Abstract][Full Text] [Related]
30. Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha2 domains.
Spreu J; Stehle T; Steinle A
J Immunol; 2006 Sep; 177(5):3143-9. PubMed ID: 16920952
[TBL] [Abstract][Full Text] [Related]
31. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
32. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais.
Romphruk AV; Romphruk A; Naruse TK; Raroengjai S; Puapairoj C; Inoko H; Leelayuwat C
Immunogenetics; 2009 Sep; 61(9):611-7. PubMed ID: 19688209
[TBL] [Abstract][Full Text] [Related]
34. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
[TBL] [Abstract][Full Text] [Related]
35. [Expression and abscission of activated receptors and their ligands on/from NK cells in peripheral blood of patients with acute leukemia].
Fang XC; Liu HL; Sun ZM; Gui L; Geng LQ; Wang XB; Zhou M; Wang ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):436-40. PubMed ID: 20416183
[TBL] [Abstract][Full Text] [Related]
36. ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients.
McGilvray RW; Eagle RA; Rolland P; Jafferji I; Trowsdale J; Durrant LG
Int J Cancer; 2010 Sep; 127(6):1412-20. PubMed ID: 20054857
[TBL] [Abstract][Full Text] [Related]
37. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.
de Kruijf EM; Sajet A; van Nes JG; Putter H; Smit VT; Eagle RA; Jafferji I; Trowsdale J; Liefers GJ; van de Velde CJ; Kuppen PJ
BMC Cancer; 2012 Jan; 12():24. PubMed ID: 22257486
[TBL] [Abstract][Full Text] [Related]
38. NKG2D ligands are expressed on stressed human airway epithelial cells.
Borchers MT; Harris NL; Wesselkamper SC; Vitucci M; Cosman D
Am J Physiol Lung Cell Mol Physiol; 2006 Aug; 291(2):L222-31. PubMed ID: 16473864
[TBL] [Abstract][Full Text] [Related]
39. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].
Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338
[TBL] [Abstract][Full Text] [Related]
40. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
Waldhauer I; Steinle A
Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
